BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 14977966)

  • 1. Novel antigen identification method for discovery of protective malaria antigens by rapid testing of DNA vaccines encoding exons from the parasite genome.
    Haddad D; Bilcikova E; Witney AA; Carlton JM; White CE; Blair PL; Chattopadhyay R; Russell J; Abot E; Charoenvit Y; Aguiar JC; Carucci DJ; Weiss WR
    Infect Immun; 2004 Mar; 72(3):1594-602. PubMed ID: 14977966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput generation of P. falciparum functional molecules by recombinational cloning.
    Aguiar JC; LaBaer J; Blair PL; Shamailova VY; Koundinya M; Russell JA; Huang F; Mar W; Anthony RM; Witney A; Caruana SR; Brizuela L; Sacci JB; Hoffman SL; Carucci DJ
    Genome Res; 2004 Oct; 14(10B):2076-82. PubMed ID: 15489329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transcriptionally active PCR for antigen identification and vaccine development: in vitro genome-wide screening and in vivo immunogenicity.
    Regis DP; Dobaño C; Quiñones-Olson P; Liang X; Graber NL; Stefaniak ME; Campo JJ; Carucci DJ; Roth DA; He H; Felgner PL; Doolan DL
    Mol Biochem Parasitol; 2008 Mar; 158(1):32-45. PubMed ID: 18164079
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A new malaria antigen produces partial protection against Plasmodium yoelii challenge.
    Zhang Y; Qi Y; Li J; Liu S; Hong L; Lin T; Long C; Su XZ
    Parasitol Res; 2012 Apr; 110(4):1337-45. PubMed ID: 21915626
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmodium: mammalian codon optimization of malaria plasmid DNA vaccines enhances antibody responses but not T cell responses nor protective immunity.
    Dobaño C; Sedegah M; Rogers WO; Kumar S; Zheng H; Hoffman SL; Doolan DL
    Exp Parasitol; 2009 Jun; 122(2):112-23. PubMed ID: 19249301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.
    Sanchez GI; Sedegah M; Rogers WO; Jones TR; Sacci J; Witney A; Carucci DJ; Kumar N; Hoffman SL
    Infect Immun; 2001 Jun; 69(6):3897-905. PubMed ID: 11349057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improving protective immunity induced by DNA-based immunization: priming with antigen and GM-CSF-encoding plasmid DNA and boosting with antigen-expressing recombinant poxvirus.
    Sedegah M; Weiss W; Sacci JB; Charoenvit Y; Hedstrom R; Gowda K; Majam VF; Tine J; Kumar S; Hobart P; Hoffman SL
    J Immunol; 2000 Jun; 164(11):5905-12. PubMed ID: 10820272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use.
    Hoffman SL; Doolan DL; Sedegah M; Aguiar JC; Wang R; Malik A; Gramzinski RA; Weiss WR; Hobart P; Norman JA; Margalith M; Hedstrom RC
    Vaccine; 1997 Jun; 15(8):842-5. PubMed ID: 9234529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Can malaria DNA vaccines on their own be as immunogenic and protective as prime-boost approaches to immunization?
    Hoffman SL; Doolan DL
    Dev Biol (Basel); 2000; 104():121-32. PubMed ID: 11713810
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence of protective immunity to malaria induced by DNA priming and poxvirus boosting: characterization of effector and memory CD8(+)-T-cell populations.
    Sedegah M; Brice GT; Rogers WO; Doolan DL; Charoenvit Y; Jones TR; Majam VF; Belmonte A; Lu M; Belmonte M; Carucci DJ; Hoffman SL
    Infect Immun; 2002 Jul; 70(7):3493-9. PubMed ID: 12065488
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against malaria by immunization with plasmid DNA encoding circumsporozoite protein.
    Sedegah M; Hedstrom R; Hobart P; Hoffman SL
    Proc Natl Acad Sci U S A; 1994 Oct; 91(21):9866-70. PubMed ID: 7937907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selection and identification of malaria vaccine target molecule using bioinformatics and DNA vaccination.
    Shuaibu MN; Kikuchi M; Cherif MS; Helegbe GK; Yanagi T; Hirayama K
    Vaccine; 2010 Oct; 28(42):6868-75. PubMed ID: 20709002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Merozoite surface protein 4/5 provides protection against lethal challenge with a heterologous malaria parasite strain.
    Goschnick MW; Black CG; Kedzierski L; Holder AA; Coppel RL
    Infect Immun; 2004 Oct; 72(10):5840-9. PubMed ID: 15385485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of transmission-blocking vaccines simultaneously targeting pre- and post-fertilization antigens in the rodent malaria parasite Plasmodium yoelii.
    Zheng L; Pang W; Qi Z; Luo E; Cui L; Cao Y
    Parasit Vectors; 2016 Aug; 9(1):433. PubMed ID: 27502144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity and protective efficacy of three DNA vaccines encoding pre-erythrocytic- and erythrocytic-stage antigens of Plasmodium cynomolgi in rhesus monkeys.
    Bhardwaj D; Hora B; Singh N; Puri SK; Lalitha P; Rupa P; Chauhan VS
    FEMS Immunol Med Microbiol; 2002 Sep; 34(1):33-43. PubMed ID: 12208604
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA immunization by Plasmodium falciparum liver-stage antigen 3 induces protection against Plasmodium yoelii sporozoite challenge.
    Sauzet JP; Perlaza BL; Brahimi K; Daubersies P; Druilhe P
    Infect Immun; 2001 Feb; 69(2):1202-6. PubMed ID: 11160023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of specific T-cell responses, opsonizing antibodies, and protection against Plasmodium chabaudi adami infection in mice vaccinated with genomic expression libraries expressed in targeted and secretory DNA vectors.
    Rainczuk A; Scorza T; Smooker PM; Spithill TW
    Infect Immun; 2003 Aug; 71(8):4506-15. PubMed ID: 12874330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhancement of antibody and cellular immune responses to malaria DNA vaccines by in vivo electroporation.
    Dobaño C; Widera G; Rabussay D; Doolan DL
    Vaccine; 2007 Sep; 25(36):6635-45. PubMed ID: 17669562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determining liver stage parasite burden by real time quantitative PCR as a method for evaluating pre-erythrocytic malaria vaccine efficacy.
    Witney AA; Doolan DL; Anthony RM; Weiss WR; Hoffman SL; Carucci DJ
    Mol Biochem Parasitol; 2001 Dec; 118(2):233-45. PubMed ID: 11738713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus.
    Oliveira-Ferreira J; Miyahira Y; Layton GT; Savage N; Esteban M; Rodriguez D; Rodriguez JR; Nussenzweig RS; Zavala F
    Vaccine; 2000 Mar; 18(17):1863-9. PubMed ID: 10699335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.